| human | Q5 |
| P6178 | Dimensions author ID | 010054353347.22 |
| P496 | ORCID iD | 0000-0002-4075-2544 |
| P1153 | Scopus author ID | 7003403928 |
| P69 | educated at | University of California, Santa Barbara | Q263064 |
| University of California, San Francisco | Q1061104 | ||
| P108 | employer | City of Hope National Medical Center | Q5123723 |
| P735 | given name | Timothy | Q15885954 |
| Timothy | Q15885954 | ||
| P106 | occupation | researcher | Q1650915 |
| Q91634208 | 8-chloro-adenosine activity in FLT3-ITD acute myeloid leukemia |
| Q91312391 | A Pilot Study of Vinorelbine Safety and Pharmacokinetics in Patients with Varying Degrees of Liver Dysfunction |
| Q34231554 | A neuropharmacokinetic assessment of bafetinib, a second generation dual BCR-Abl/Lyn tyrosine kinase inhibitor, in patients with recurrent high-grade gliomas |
| Q35190641 | A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia |
| Q35782691 | A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study. |
| Q47565783 | A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy. |
| Q41652561 | A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study |
| Q33396761 | A phase I study of bortezomib and temozolomide in patients with advanced solid tumors. |
| Q90953961 | A phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity |
| Q46086114 | A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus-induced prostate-specific antigen responses |
| Q91056362 | A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors |
| Q38428175 | A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168). |
| Q38429571 | A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial. |
| Q36090064 | A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agent |
| Q35000541 | A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance |
| Q35660934 | Advanced glycation end products of DNA: quantification of N2-(1-Carboxyethyl)-2'-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry |
| Q34959972 | Age-related changes in nanoparticle albumin-bound paclitaxel pharmacokinetics and pharmacodynamics: influence of chronological versus functional age |
| Q38282658 | Antivirulence potential of TR-700 and clindamycin on clinical isolates of Staphylococcus aureus producing phenol-soluble modulins. |
| Q36112971 | AroER tri-screen™ is a novel functional assay to estimate both estrogenic and estrogen precursor activity of chemicals or biological specimens. |
| Q46189138 | Association of Pre-Chemotherapy Peripheral Blood Pro-Inflammatory and Coagulation Factors with Physical Function in Women with Breast Cancer |
| Q38636006 | Association of pre-chemotherapy peripheral blood pro-inflammatory and coagulation factors with reduced relative dose intensity in women with breast cancer |
| Q34349328 | Atherogenic diets exacerbate colitis in mice deficient in glutathione peroxidase. |
| Q36852597 | Bioimaging real-time PXR-dependent mdr1a gene regulation in mdr1a.fLUC reporter mice. |
| Q46764721 | Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib. |
| Q46979100 | Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU). |
| Q33895729 | DNA lesions induced by UV A1 and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor gene. |
| Q33194233 | Effect of valspodar on the pharmacokinetics of unbound paclitaxel |
| Q45168481 | Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors |
| Q44918484 | Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies. |
| Q99207673 | Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients |
| Q44946226 | G-to-T transversions and small tandem base deletions are the hallmark of mutations induced by ultraviolet a radiation in mammalian cells. |
| Q49990061 | HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational ART. |
| Q38977723 | Iron chelators induce autophagic cell death in multiple myeloma cells |
| Q46521216 | Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis. |
| Q38439120 | Low Testosterone Alters the Activity of Mouse Prostate Stem Cells |
| Q91848730 | Molecular Mechanisms of Polybrominated Diphenyl Ethers (BDE-47, BDE-100, and BDE-153) in Human Breast Cancer Cells and Patient-Derived Xenografts |
| Q39585359 | Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of SREBP-1 and ATF6. |
| Q39097305 | Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients. |
| Q34110178 | Neural stem cell-mediated CE/CPT-11 enzyme/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma. |
| Q37344283 | Neural stem cell-mediated delivery of irinotecan-activating carboxylesterases to glioma: implications for clinical use. |
| Q40449697 | Oblimersen and alpha-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium. |
| Q37718554 | Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma |
| Q80798273 | Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function |
| Q79563377 | Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer |
| Q44605680 | Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the national cancer institute organ dysfunction working group |
| Q36980076 | Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study. |
| Q34687059 | Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors. |
| Q46466258 | Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity. |
| Q46002146 | Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial. |
| Q35463268 | Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia. |
| Q44561304 | Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products. |
| Q64228487 | Quantitative Evaluation of Intraventricular Delivery of Therapeutic Neural Stem Cells to Orthotopic Glioma |
| Q45174872 | Similar mutagenicity of photoactivated porphyrins and ultraviolet A radiation in mouse embryonic fibroblasts: involvement of oxidative DNA lesions in mutagenesis. |
| Q91178625 | Single-cell RNA-sequencing analysis of estrogen- and endocrine-disrupting chemical-induced reorganization of mouse mammary gland |
| Q89393362 | The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA |
| Q42573064 | Tigecycline induction of phenol-soluble modulins by invasive methicillin-resistant Staphylococcus aureus strains. |
Search more.